NCI Explores AI’s Potential for Cancer Screenings
Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, NCI
The National Cancer Institute (NCI) is exploring how it can leverage artificial intelligence to enhance cancer screening techniques, ultimately improving patient outcomes across the nation.
Dr. Katrina Goddard, director of the Division of Cancer Control and Population Sciences at NCI, explains how her division is leveraging AI, and other innovative solutions like the low-dose CT scan, to better detect lung cancer and enable better access to data.
Goddard also shares details from a recent study that highlighted the major role screenings and prevention have played in decreasing the cancer mortality rates over the past 40 years.
-
Dr. Katrina Goddard Director, Division of Cancer Control and Population Sciences, NCI
-
HHS Identifies Three Priorities for Clinical AI Adoption
Officials outlined efforts for implementation support, coordination and evaluation standards with new AI regulatory proposals expected soon.
5m read -
DOT Pushes Toward Passwordless Future as Zero-Trust Matures
Enterprise Security Architect Austin Clark says zero-trust adoption is accelerating as users embrace faster, more secure authentication experiences.
10m watch -
Misunderstood ATOs Are Costing Agencies Time, Money
Institutional confusion about ATOs is creating avoidable delays, while modern DevSecOps approaches offer a faster path to software delivery.
9m watch -
Building the Foundation for AI
FBI and NIH explore how data modernization and cybersecurity are shaping federal artificial intelligence adoption.
27m watch Partner Content
